OR WAIT 15 SECS
The Biotechnology Industry Organization announced a name change to the Biotechnology Innovation Organization, effective in early 2016.
The Biotechnology Industry Organization (BIO) will become the Biotechnology Innovation Organization in early 2016, announced Ron Cohen, CEO of Acorda Therapeutics, and the organization’s new board chair, during a June 17 keynote session at the 2015 BIO International Convention in Philadelphia.
“I’m pleased to announce that the BIO Board has approved a change to BIO’s name … from the Biotechnology Industry Organization to the Biotechnology Innovation Organization. Still BIO, but now with a name that better expresses the essence of what our member companies represent,” said Cohen.
“This is a great move that will help clarify for policymakers and the public the heart of our industry-scientific innovation that will help to heal, feed, and fuel the world. Each day, our members use cutting edge science and technology to deliver game-changing products, therapies, and cures to improve the human condition,” said BIO’s President and CEO, Jim Greenwood.
BIO is a trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.